The ability of Tam repressing Pol III gene transcription may have important implications for the development of Pol III gene lowering medications by using possible inhibitors of c-Jun or Brf1 to improve the efficacy of Tam treatment of breast cancer. The gene discussed is JUN; the disease is breast carcinoma.